UCB at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
UCB takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover intellectual property strategy in early biomanufacturing and women's health as healthcare's largest underserved market. The biomanufacturing session looks at building competitive advantage from day one.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
UCB Brussels, Belgium | |
Biopharmaceutical company developing and marketing medicines for immunology and neurology. | Panel Tue Nov 10 14:30–14:55 Intellectual Property Strategy in Early-Stage Biomanufacturing: Building Competitive Advantage from Day One Whether young companies should patent a new manufacturing process or keep it secret, and how to show partners their intellectual property holds up. Panel Tue Nov 10 11:15–12:15 Women’s Health: Healthcare’s Largest Underserved Market and Biggest Growth Opportunity Why women's health is a large, neglected market, and how much value is lost when medicine is designed around the wrong default patient. Therapeutic InsightsBusiness of Biotech |
Instantly find 20 buyers from UCB
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction